We are pleased to present below all posts archived in 'April, 2016'. If you still can't find what you are looking for, try using the search box.
Abingdon Health Ltd (“Abingdon Health”) today announces the signing of a collaboration agreement with Sumitomo Chemical Co., Ltd (“Sumitomo Chemical”) to develop a next generation multiplexed point of care biosensor device.
Read the rest of entry »
As the prevalence of cardiovascular disease (CVD) continues to grow, Rhys Tassell, Point of Care Testing Team Lead at Cambridge University Hospitals NHS Foundation Trust explains how Addenbrooke’s Hospital’s Emergency Department is ensuring a swift diagnosis at the point-of-care.
Binding Site is delighted and humbled to announce that it has been awarded a Queen’s award for enterprise - the UK’s highest accolade for business success. The honour has been awarded in the category of ‘International Trade’.
Do you need to mail samples of fluids in volumes up to 120ml?
SpeciSafe® secondary packaging containers provide a safe, convenient and economical solution for compliant mailing of biohazardous and clinical specimens. The extensive SpeciSafe range includes solutions for screw cap microtubes, serum vials, vacuum blood collection tubes, cryovials, Bijou containers, swabs/transport tubes, universal containers and is now extended to include a pack to seal SampleTite™ or similar 40ml, 60ml or 90ml containers.
Findings from Sheffield Teaching Hospitals NHS Trust
Nyon, Switzerland — (20 April 2016) — Beckman Coulter today announced that the Sheffield Teaching Hospitals Virology Department is the first site to introduce the company’s DxN VERIS HBV assay* routinely. Operating on the DxN VERIS Molecular Diagnostics System, that consolidates DNA extraction, amplification and detection within a single automated instrument, the HBV assay will allow the laboratory to offer service users greater precision at low HBV viral loads as well as improved turnaround times.
Faecal calprotectin (fCAL) has become an increasingly important biomarker for in vitro diagnostic detection of gut inflammation. It enables clinicians to make initial diagnostic predictions without the need for invasive and costly endoscopies. With the advent of NICE diagnostics guidance [DG11], the demand for faecal calprotectin testing has risen significantly.
5th April 2016; Cobham, UK. As global experts in mapping and analysis of protein changes in systems-wide biology, Proteome Sciences plc is strongly encouraged by two recent reports that emphasise the importance of protein profiling to improve outcomes in cancer treatment. These highlight the growing need for more detailed, personal assessment of protein profiles to improve the management of cancer treatment.
Niguarda Hospital case study now available
Nyon, Switzerland — (30 March 2016) — A case study describing the experiences of Niguarda Hospital, Milan, in assessing the new DxN VERIS Molecular Diagnostics System is now available from Beckman Coulter. The case study describes the workflow improvements and reduced turnaround times that the hospital’s Molecular Biology Laboratory was able to achieve for viral load measurements using the DxN VERIS system.
Who are the BIVDA Members
Member Press Releases
Point of Care Directory
News, Policy and Media
BIVDA Press Releases